Patents Assigned to CPSI Holdings LLC
  • Patent number: 10336984
    Abstract: A novel class of agents has been identified to serve as cell-guard agents and/or target-specific supplements to increase cell quality and yield, as well as select for target cell populations. Several additive agents (both natural and synthetic) have been identified, including Vitamin D3, NAC, resveratrol, salubrinal, AKT, and tunicamycin (among others) that hold promise for application in cell models. In one embodiment, hypothermic stress regimes are utilized. In another embodiment, normothermic conditions are utilized while other stressors are tested in the processing. The methods of maintaining mass cell cultures and/or selecting out particular cell populations for further research and clinical use represents an important step in therapeutic discovery.
    Type: Grant
    Filed: August 6, 2015
    Date of Patent: July 2, 2019
    Assignee: CPSI Holdings LLC
    Inventors: John M. Baust, John G. Baust, William L. Corwin, Robert G. Van Buskirk
  • Patent number: 10196598
    Abstract: A system for heating or cooling a sample is disclosed, which includes an insulated chamber; at least one of a heater or a cooling pad disposed within the chamber; and at least one compliant, fluid filled pillow. The at least one compliant, fluid-filled pillow is disposed in the chamber and adjacent to the at least one thermal device while being heated or cooled to a desired temperature by the heater or the cooling pad, and upon reaching the desired temperature, the at least one compliant, fluid filled pillow substantially conforms to a container containing the sample.
    Type: Grant
    Filed: October 6, 2015
    Date of Patent: February 5, 2019
    Assignee: CPSI HOLDINGS LLC
    Inventors: John M. Baust, Joshua T. Smith, William Corwin, Kristi Snyder, Anthony T. Robilotto
  • Patent number: 10054262
    Abstract: A cryogenic system as well as a method of generating a pressurized, sub-cooled mixed-phase cryogen and a method of delivering such a cryogen to a cryoprobe are disclosed. In an embodiment, the cryogenic system includes a reservoir containing a liquid cryogen and a sub-cooling coil immersed in the liquid cryogen. The cryogen is supplied to the sub-cooling coil and is cooled under pressure to produce a pressurized mixed phase cryogen within the sub-cooling coil. This pressurized mixed phase cryogen is provided via supply line to a cryo-device for use.
    Type: Grant
    Filed: April 15, 2015
    Date of Patent: August 21, 2018
    Assignee: CPSI Holdings LLC
    Inventors: John M. Baust, Joshua T. Smith, Anthony T. Robilotto, Jennie F. McKain
  • Patent number: 10039586
    Abstract: The present disclosure relates to a thermal ablation probe device that integrates deployable sensors with a freezing probe or heating probe for use in ablating tissues. The ablation probe includes a longitudinal body including a thermal ablation energy source which may be, e.g., a cryosource or a heat source. The longitudinal body has a proximal end and a distal end terminating at a probe tip; and at least one deployable assembly disposed within the longitudinal body. The deployable assembly includes a flexible and substantially rigid deployment member, and at least one sensor affixed to a distal end of the deployment member. The ablation probe further includes a control mechanism for controlling deployment and retraction of the deployable assembly.
    Type: Grant
    Filed: February 26, 2014
    Date of Patent: August 7, 2018
    Assignee: CPSI Holdings LLC
    Inventors: Marie Molnar-Hammond, John M. Baust
  • Patent number: 9932551
    Abstract: A tissue engineered model (TEM) structure, an apparatus and method for making a TEM structure, and methods of using a TEM structure are disclosed. In an embodiment, the TEM structure includes at least one TEM segment. Each TEM segment includes a frame defining a bounded area, the frame having a height, a first edge, and a second edge opposite the first edge, each of the first edge and the second edge defining a perimeter of the bounded area, and the height defining a distance between the first edge and the second edge; a membrane affixed to the first edge about a perimeter of the frame; and a solidified gel and cell matrix disposed within the bounded area within the frame, wherein the solidified gel and cell matrix substantially fills a volume defined by the bounded area and the height of the frame.
    Type: Grant
    Filed: March 20, 2017
    Date of Patent: April 3, 2018
    Assignee: CPSI Holdings LLC
    Inventors: John G. Baust, Joshua T. Smith, Kimberly L. Santucci, Kristi K. Snyder, Anthony T. Robilotto, Robert G. Van Buskirk, John M. Baust, William L. Corwin, Jennie F. McKain
  • Patent number: 9895184
    Abstract: The invention is a multi-functional ablation device that encompasses the use of both heat energy and cryogenic energy as integrated into one medical device. In one embodiment, the medical device integrates a heat source such as RF or HIFU in combination with a source of cryogenic energy such that the multi-functional ablation device is a dual thermal ablation device capable of utilizing either energy source alone or in combination.
    Type: Grant
    Filed: December 6, 2016
    Date of Patent: February 20, 2018
    Assignee: CPSI Holdings LLC
    Inventor: John M. Baust
  • Patent number: 9877767
    Abstract: An endoscopic cryoablation apparatus for the ablation of unwanted tissues is disclosed. A method of utilizing the apparatus for ablating pancreatic cancer, gastrointestinal cancers, or other undesired tissue is also incorporated. The apparatus provides a cryoprobe needle tip covered by an outer sheath at a distal end of a catheter shaft such that the distal end includes a defined ablation zone. As implemented, the cryocatheter can be utilized alone or in combination with and endoscopic ultrasound. A moveable handle attached to the outer sheath is configured such that the handle retracts and protracts the outer sheath to expose and cover, respectively, the cryoprobe needle tip.
    Type: Grant
    Filed: July 9, 2013
    Date of Patent: January 30, 2018
    Assignee: CPSI Holdings LLC
    Inventor: John M Baust
  • Patent number: 9631173
    Abstract: A tissue engineered model (TEM) structure, an apparatus and method for making a TEM structure, and methods of using a TEM structure are disclosed. In an embodiment, the TEM structure includes at least one TEM segment. Each TEM segment includes a frame defining a bounded area, the frame having a height, a first edge, and a second edge opposite the first edge, each of the first edge and the second edge defining a perimeter of the bounded area, and the height defining a distance between the first edge and the second edge; a membrane affixed to the first edge about a perimeter of the frame; and a solidified gel and cell matrix disposed within the bounded area within the frame, wherein the solidified gel and cell matrix substantially fills a volume defined by the bounded area and the height of the frame.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: April 25, 2017
    Assignee: CPSI Holdings LLC
    Inventors: John G. Baust, Joshua T. Smith, Kimberly L. Santucci, Kristi K. Snyder, Anthony T. Robilotto, Robert G. Van Buskirk, John M. Baust, William L. Corwin, Jennie F. McKain
  • Publication number: 20170086902
    Abstract: The invention is a multi-functional ablation device that encompasses the use of both heat energy and cryogenic energy as integrated into one medical device. In one embodiment, the medical device integrates a heat source such as RF or HIFU in combination with a source of cryogenic energy such that the multi-functional ablation device is a dual thermal ablation device capable of utilizing either energy source alone or in combination.
    Type: Application
    Filed: December 6, 2016
    Publication date: March 30, 2017
    Applicant: CPSI HOLDINGS LLC
    Inventor: John M. Baust
  • Patent number: 9566105
    Abstract: The invention is a multi-functional ablation device that encompasses the use of both heat energy and cryogenic energy as integrated into one medical device. In one embodiment, the medical device integrates a heat source such as RF or HIFU in combination with a source of cryogenic energy such that the multi-functional ablation device is a dual thermal ablation device capable of utilizing either energy source alone or in combination.
    Type: Grant
    Filed: February 7, 2013
    Date of Patent: February 14, 2017
    Assignee: CPSI Holdings LLC
    Inventor: John M. Baust
  • Patent number: 9213025
    Abstract: A tissue engineered model (TEM) structure, an apparatus and method for making a TEM structure, and methods of using a TEM structure are disclosed. In an embodiment, the TEM structure includes at least one TEM segment. Each TEM segment includes a frame defining a bounded area, the frame having a height, a first edge, and a second edge opposite the first edge, each of the first edge and the second edge defining a perimeter of the bounded area, and the height defining a distance between the first edge and the second edge; a membrane affixed to the first edge about a perimeter of the frame; and a solidified gel and cell matrix disposed within the bounded area within the frame, wherein the solidified gel and cell matrix substantially fills a volume defined by the bounded area and the height of the frame.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: December 15, 2015
    Assignee: CPSI Holdings LLC
    Inventors: John G. Baust, Joshua T. Smith, Kimberly L. Santucci, Kristi K. Snyder, Anthony T. Robilotto, Robert G. Van Buskirk, John M. Baust, William L. Corwin, Jennie F. McKain
  • Publication number: 20140273063
    Abstract: A tissue engineered model (TEM) structure, an apparatus and method for making a TEM structure, and methods of using a TEM structure are disclosed. In an embodiment, the TEM structure includes at least one TEM segment. Each TEM segment includes a frame defining a bounded area, the frame having a height, a first edge, and a second edge opposite the first edge, each of the first edge and the second edge defining a perimeter of the bounded area, and the height defining a distance between the first edge and the second edge; a membrane affixed to the first edge about a perimeter of the frame; and a solidified gel and cell matrix disposed within the bounded area within the frame, wherein the solidified gel and cell matrix substantially fills a volume defined by the bounded area and the height of the frame.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Applicant: CPSI HOLDINGS LLC
    Inventors: John G. BAUST, Joshua T. SMITH, Kimberly L. SANTUCCI, Kristi K. SNYDER, Anthony T. ROBILOTTO, Robert G. VAN BUSKIRK, John M. BAUST, William L. CORWIN, Jennie F. MCKAIN
  • Publication number: 20140243808
    Abstract: The present disclosure relates to a thermal ablation probe device that integrates deployable sensors with a freezing probe or heating probe for use in ablating tissues. The ablation probe includes a longitudinal body including a thermal ablation energy source which may be, e.g., a cryosource or a heat source. The longitudinal body has a proximal end and a distal end terminating at a probe tip; and at least one deployable assembly disposed within the longitudinal body. The deployable assembly includes a flexible and substantially rigid deployment member, and at least one sensor affixed to a distal end of the deployment member. The ablation probe further includes a control mechanism for controlling deployment and retraction of the deployable assembly.
    Type: Application
    Filed: February 26, 2014
    Publication date: August 28, 2014
    Applicant: CPSI HOLDINGS LLC
    Inventors: Marie Molnar-Hammond, John M. Baust
  • Patent number: 8747397
    Abstract: The resorbable cryoprobe device and process is a novel approach for treating localized disease allowing for the precise combined application of freezing temperatures and cytotoxic or cryosensitizing agents within a self-contained matrix/package for optimized tissue destruction. The cryopellet is comprised of a list of components including a source of cryogen to produce the sub-zero temperatures, a porous matrix to contain the cytotoxic agent, cytotoxic agent, and a delivery packet. Data presented herein demonstrates the efficacy of this approach in destroying cancerous tissue. For example, the application of freezing temperatures to ?10° C. results in approximately 15% cell death, while exposure to cytotoxic agents such as TRAIL produces minimal cell death. The utilization of the cryopellet approach results in a synergistic effect yielding complete cell death at the same temperature.
    Type: Grant
    Filed: November 21, 2012
    Date of Patent: June 10, 2014
    Assignee: CPSI Holdings LLC
    Inventors: John M. Baust, John G. Baust, Anthony T. Robilotto, Kristi K. Snyder, Robert G. Van Buskirk
  • Publication number: 20130204241
    Abstract: The invention is a multi-functional ablation device that encompasses the use of both heat energy and cryogenic energy as integrated into one medical device. In one embodiment, the medical device integrates a heat source such as RF or HIFU in combination with a source of cryogenic energy such that the multi-functional ablation device is a dual thermal ablation device capable of utilizing either energy source alone or in combination.
    Type: Application
    Filed: February 7, 2013
    Publication date: August 8, 2013
    Applicant: CPSI HOLDINGS LLC
    Inventor: CPSI HOLDINGS LLC
  • Patent number: 8409184
    Abstract: The resorbable cryoprobe device and process is a novel approach for treating localized disease allowing for the precise combined application of freezing temperatures and cytotoxic or cryosensitizing agents within a self-contained matrix/package for optimized tissue destruction. The cryopellet is comprised of a list of components including a source of cryogen to produce the sub-zero temperatures, a porous matrix to contain the cytotoxic agent, cytotoxic agent, and a delivery packet. Data presented herein demonstrates the efficacy of this approach in destroying cancerous tissue. For example, the application of freezing temperatures to ?10° C. results in approximately 15% cell death, while exposure to cytotoxic agents such as TRAIL produces minimal cell death. The utilization of the cryopellet approach results in a synergistic effect yielding complete cell death at the same temperature.
    Type: Grant
    Filed: October 28, 2009
    Date of Patent: April 2, 2013
    Assignee: CPSI Holdings LLC
    Inventors: John M. Baust, John G. Baust, Anthony T. Robilotto, Kristi K. Snyder, Robert G. Van Buskirk
  • Publication number: 20130079761
    Abstract: The resorbable cryoprobe device and process is a novel approach for treating localized disease allowing for the precise combined application of freezing temperatures and cytotoxic or cryosensitizing agents within a self-contained matrix/package for optimized tissue destruction. The cryopellet is comprised of a list of components including a source of cryogen to produce the sub-zero temperatures, a porous matrix to contain the cytotoxic agent, cytotoxic agent, and a delivery packet. Data presented herein demonstrates the efficacy of this approach in destroying cancerous tissue. For example, the application of freezing temperatures to ?10° C. results in approximately 15% cell death, while exposure to cytotoxic agents such as TRAIL produces minimal cell death. The utilization of the cryopellet approach results in a synergistic effect yielding complete cell death at the same temperature.
    Type: Application
    Filed: November 21, 2012
    Publication date: March 28, 2013
    Applicant: CPSI HOLDINGS LLC
    Inventor: CPSI HOLDINGS LLC